Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cushing Syndrome 4 ACTH Syndrome, Ectopic 4 Pituitary Diseases 3 Pituitary ACTH Hypersecretion 3 Hirsutism 2 Choristoma 2 Adrenal Cortex Neoplasms 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Leiomyoma 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1

Interventions

telapristone acetate 13 estradiol, norethindrone drug combination 9 elagolix 7 Estradiol 7 relugolix 6 Norethindrone Acetate 5 vilaprisan 4 ulipristal acetate 4 Sugars 3 Uterine Myomectomy 2 Lidocaine 2 Leuprolide 2 Letrozole 2 ulipristal 1 epigallocatechin gallate 1 Vitamin B 6 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Therapeutics 1 Standard of Care 1 Sodium Chloride 1 Ropivacaine 1 Rocuronium 1 Progesterone 1 Pregabalin 1 Morphine 1 Misoprostol 1 Mifepristone 1 Injections, Subcutaneous 1 Ibuprofen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Leiomyoma × Mifepristone × Clear all

NCT00133705 2023-09-25

Trial of Mifepristone for Fibroids

University of Rochester

Phase 3 Completed

70 enrolled 6 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡